Stimcell Energetics (STME) EBT Margin Growth (1y) (2017 - 2023)
Stimcell Energetics (STME) EBT Margin Growth (1y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -287.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 772.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 233.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -464.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2023 | -9.36 Mn |
| Feb 28, 2023 | -2.49 Mn |
| Nov 30, 2022 | -705,657.00 |
| Aug 31, 2022 | -998,172.00 |
| May 31, 2022 | 34,897.00 |
| Feb 28, 2022 | -1.97 Mn |
| Nov 30, 2021 | -41,173.00 |
| Aug 31, 2021 | -628,079.00 |
| May 31, 2021 | -1.37 Mn |
| Feb 28, 2021 | 639,879.00 |
| Nov 30, 2020 | -715,489.00 |
| Aug 31, 2020 | -1.25 Mn |
| Feb 28, 2017 | -4.59 Mn |